These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 18188617)
1. Population pharmacokinetic and pharmacodynamic modeling of norvancomycin. Zhang J; Zhang Y; Shi Y; Rui J; Yu J; Cao G; Wu J Eur J Clin Microbiol Infect Dis; 2008 Apr; 27(4):275-84. PubMed ID: 18188617 [TBL] [Abstract][Full Text] [Related]
2. Factors Influencing Norvancomycin Concentration in Plasma and Cerebrospinal Fluid in Patients After Craniotomy and Dosing Guideline: A Population Approach. Li X; Wu Y; Sun S; Wang Q; Zhao Z Clin Ther; 2018 Jan; 40(1):74-82.e1. PubMed ID: 29229228 [TBL] [Abstract][Full Text] [Related]
3. Population Pharmacokinetics and Pharmacodynamics of Norvancomycin in Children With Malignant Hematological Disease. Wang J; Li SC; Ye Q; Gao LL; Nie YM; Xu H; Wu M; Cao P; Wang Y J Clin Pharmacol; 2020 Sep; 60(9):1220-1230. PubMed ID: 32488878 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of vancomycin in extremely obese patients with suspected or confirmed Staphylococcus aureus infections. Adane ED; Herald M; Koura F Pharmacotherapy; 2015 Feb; 35(2):127-39. PubMed ID: 25644478 [TBL] [Abstract][Full Text] [Related]
5. Vancomycin dosing assessment in intensive care unit patients based on a population pharmacokinetic/pharmacodynamic simulation. Revilla N; Martín-Suárez A; Pérez MP; González FM; Fernández de Gatta Mdel M Br J Clin Pharmacol; 2010 Aug; 70(2):201-12. PubMed ID: 20653673 [TBL] [Abstract][Full Text] [Related]
6. Population Pharmacokinetic Analysis of Doripenem after Intravenous Infusion in Korean Patients with Acute Infections. Lee DH; Kim YK; Jin K; Kang MJ; Joo YD; Kim YW; Moon YS; Shin JG; Kiem S Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223378 [TBL] [Abstract][Full Text] [Related]
7. Population Pharmacokinetic Model for Vancomycin Used in Open Heart Surgery: Model-Based Evaluation of Standard Dosing Regimens. Alqahtani SA; Alsultan AS; Alqattan HM; Eldemerdash A; Albacker TB Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29686154 [TBL] [Abstract][Full Text] [Related]
8. Model-based Evaluation of the Clinical and Microbiological Efficacy of Vancomycin: A Prospective Study of Chinese Adult In-house Patients. Shen K; Yang M; Fan Y; Liang X; Chen Y; Wu J; Yu J; Zhang H; Wang R; Zhang F; Hang J; Wen X; Li H; Shen L; Zhang Z; Wu S; Shen B; Huang W; Chang C; Shen Y; Ren H; Yuan Q; Song X; Luo X; Zhang H; Yang W; Yang J; Zhang J Clin Infect Dis; 2018 Nov; 67(suppl_2):S256-S262. PubMed ID: 30423042 [TBL] [Abstract][Full Text] [Related]
9. Association of the clinical efficacy of vancomycin with the novel pharmacokinetic parameter area under the trough level (AUTL) in elderly patients with hospital-acquired pneumonia. Fukumori S; Tsuji Y; Mizoguchi A; Kasai H; Ishibashi T; Iwamura N; To H J Clin Pharm Ther; 2016 Aug; 41(4):399-402. PubMed ID: 27144370 [TBL] [Abstract][Full Text] [Related]
10. Population pharmacokinetics of meropenem in elderly patients: dosing simulations based on renal function. Usman M; Frey OR; Hempel G Eur J Clin Pharmacol; 2017 Mar; 73(3):333-342. PubMed ID: 27966034 [TBL] [Abstract][Full Text] [Related]
11. The integrated use of pharmacokinetic and pharmacodynamic models for the definition of breakpoints. Stass H; Dalhoff A Infection; 2005 Dec; 33 Suppl 2():29-35. PubMed ID: 16518709 [TBL] [Abstract][Full Text] [Related]
12. Dose findings of antofloxacin hydrochloride for treating bacterial infections in an early clinical trial using PK-PD parameters in healthy volunteers. Li YF; Wang K; Yin F; He YC; Huang JH; Zheng QS Acta Pharmacol Sin; 2012 Nov; 33(11):1424-30. PubMed ID: 22864303 [TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic modelling of serum and bronchial concentrations for clarithromycin and telithromycin, and site-specific pharmacodynamic simulation for their dosages. Ikawa K; Kikuchi E; Kikuchi J; Nishimura M; Derendorf H; Morikawa N J Clin Pharm Ther; 2014 Aug; 39(4):411-7. PubMed ID: 24661290 [TBL] [Abstract][Full Text] [Related]
14. Correlation of the vancomycin 24-h area under the concentration-time curve (AUC Issaranggoon Na Ayuthaya S; Katip W; Oberdorfer P; Lucksiri A Int J Infect Dis; 2020 Mar; 92():151-159. PubMed ID: 31935538 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of vancomycin and dosing recommendations for trauma patients. Medellín-Garibay SE; Ortiz-Martín B; Rueda-Naharro A; García B; Romano-Moreno S; Barcia E J Antimicrob Chemother; 2016 Feb; 71(2):471-9. PubMed ID: 26568565 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic/pharmacodynamic analysis of vancomycin in ICU patients. del Mar Fernández de Gatta Garcia M; Revilla N; Calvo MV; Domínguez-Gil A; Sánchez Navarro A Intensive Care Med; 2007 Feb; 33(2):279-85. PubMed ID: 17165021 [TBL] [Abstract][Full Text] [Related]
17. Population Pharmacokinetic Model-Based Evaluation of Standard Dosing Regimens for Cefuroxime Used in Coronary Artery Bypass Graft Surgery with Cardiopulmonary Bypass. Alqahtani SA; Alsultan AS; Alqattan HM; Eldemerdash A; Albacker TB Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358296 [TBL] [Abstract][Full Text] [Related]
18. Drug concentrations in the serum and cerebrospinal fluid of patients treated with norvancomycin after craniotomy. Wu Y; Kang J; Wang Q Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):305-311. PubMed ID: 27738856 [TBL] [Abstract][Full Text] [Related]
19. Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations. Thomson AH; Staatz CE; Tobin CM; Gall M; Lovering AM J Antimicrob Chemother; 2009 May; 63(5):1050-7. PubMed ID: 19299472 [TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics of vancomycin in Japanese adult patients. Yasuhara M; Iga T; Zenda H; Okumura K; Oguma T; Yano Y; Hori R Ther Drug Monit; 1998 Apr; 20(2):139-48. PubMed ID: 9558127 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]